JD

Joydeb Debnath

Active Director Director DIN 07648212
DIN 07648212 First appointment Jan 2017 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Joydeb Debnath

Data last updated:

Joydeb Debnath is a Director at Alfex Healthcare Private Limited (since 2017). The company operates in Trading.

DIN 07648212
Primary Designation Director
Industry Trading
First Appointment 06 Jan 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alfex Healthcare Private Limited U51909WB2017PTC218862
Director06 Jan 20172017Under Process Of Striking Off

Board colleagues of Joydeb Debnath

NameDINCompanyDesignation
Amarjit Saha07648218Alfex Healthcare Private LimitedDirector
Sayak Dey07637868Alfex Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alfex Healthcare Private Limited
Premium access

Shareholding and investment profile for Joydeb Debnath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Joydeb Debnath

Joydeb Debnath currently holds 1 directorship: Alfex Healthcare Private Limited (Director, since 06 Jan 2017).

Joydeb Debnath was first appointed on 06 Jan 2017 as Director at Alfex Healthcare Private Limited.

The current boards of Joydeb Debnath's companies include Amarjit Saha (Alfex Healthcare Private Limited), Sayak Dey (Alfex Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available